Evidence suggests that S100B may regulate plaque formation as the knockout of S100B in the PS/APP AD mouse model selectively decreases plaque load in the cortical region (Roltsch et al., 2010) and the overexpression of S100B increases Aβ levels and deposits, at early stages (Mori et al., 2010). Here, APP is linked to Alzheimer disease.